Federal Motor Carrier Safety Administration (FMCSA), DOT.
Notice of Medical Review Board (MRB) public meeting.
FMCSA announces a public meeting of the Agency's MRB. The MRB public meeting will provide the public an opportunity to observe MRB deliberations about FMCSA's medical standards and provide comments to the MRB in accordance with the Federal Advisory Committee Act (FACA).
The MRB meeting will be held from 9 a.m. to 5:40 p.m. on Wednesday, January 6, 2010. Please refer to the preliminary agenda for this meeting in the SUPPLEMENTARY INFORMATION section of this notice for specific information.
The meeting will take place at the United States Department of Transportation, West Building Ground Floor, Oklahoma Room, 1200 New Jersey Avenue, SE., Washington, DC 20590. You may submit comments bearing the Federal Docket Management System (FDMS) Docket ID FMCSA-2009-0343 using any of the following methods:
- Federal eRulemaking Portal: Go to http://www.regulations.gov. Follow the on-line instructions for submitting comments.
- Mail: Docket Management Facility; U.S. Department of Transportation, 1200 New Jersey Avenue, SE., West Building Ground Floor, Room W12-140, Washington, DC 20590-0001.
- Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal Holidays.
- Fax: 1-202-493-2251.
Each submission must include the Agency name and the docket ID for this Notice. Note that DOT posts all comments received without change to http://www.regulations.gov, including any personal information included in a comment. Please see the Privacy Act heading below.
Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov at any time or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue, SE., Washington, DC, between Start Printed Page 641219 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The FDMS is available 24 hours each day, 365 days each year. If you want acknowledgment that we received your comments, please include a self-addressed, stamped envelope or postcard or print the acknowledgement page that appears after submitting comments on-line.
Privacy Act: Anyone may search the electronic form of all comments received into any of our dockets by the name of the individual submitting the comment (or of the person signing the comment, if submitted on behalf of an association, business, labor union, etc.).Start Further Info
FOR FURTHER INFORMATION CONTACT:
Dr. Mary D. Gunnels, Director, Medical Programs, (202) 366-4001, email@example.com, FMCSA, Department of Transportation, 1200 New Jersey Avenue, SE., Room W64-224, Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday, except Federal holidays.
Information On Services for Individuals With Disabilities: For information on facilities or services for individuals with disabilities or to request special assistance at the meeting, contact Jennifer Musick at 703-998-0189 ext. 237.End Further Info End Preamble Start Supplemental Information
The preliminary agenda for the meeting includes:
0900-0910 Call to Order, Introduction and Agenda Review
0910-0915 Medical Review Board (MRB) vote on Minutes of the July 1, 2009 Meeting
0915-0945 Parkinson's Disease, Multiple Sclerosis and Commercial Motor Vehicle (CMV) safety: Evidence Report Findings
0945-1015 Parkinson's Disease, Multiple Sclerosis and CMV safety: Medical Expert Panel (MEP) Opinion
1015-1045 Ad hoc Committee Report on Parkinson's disease, Multiple Sclerosis and CMV safety
1045-1100 Public Comment on Parkinson's disease, Multiple Sclerosis and CMV safety
1115-1145 MRB Deliberations on Parkinson's disease, Multiple Sclerosis and CMV safety
1145-1215 Narcolepsy (with and without Cataplexy) and CMV Driver Safety: Evidence Report Findings
1215-1315 Lunch (on your own)
1315-1345 Ad hoc Committee Report on Narcolepsy and CMV Driver Safety
1345-1400 Public Comment on Narcolepsy (with and without Cataplexy) and CMV Driver Safety
1400-1430 MRB Deliberation on Narcolepsy (with and without Cataplexy) and CMV Driver Safety
1430-1500 Traumatic Brain Injury and CMV Driver Safety: Evidence Report Findings
1500-1515 Break **
1515-1545 Traumatic Brain Injury and CMV Driver Safety: MEP Opinion
1545-1600 Public Comment on Traumatic Brain Injury and CMV Driver Safety
1600-1630 MRB Deliberation on Traumatic Brain Injury and CMV Driver Safety
1630-1700 Ad hoc Committee Report on Psychiatric Disorders and CMV Driver Safety
1700-1730 MRB Deliberation on Psychiatric Disorders and CMV Driver Safety
1730-1740 MRB Further Business
1740 Call to Adjourn
** Breaks will be announced on meeting day and may be adjusted according to schedule changes, other meeting requirements.
The U.S. Secretary of Transportation announced on March 7, 2006, the five medical experts who serve on the MRB. Section 4116 of the Safe, Accountable, Flexible, Efficient Transportation Equity Act: A Legacy for Users (SAFETEA-LU, Pub. L. 109-59) requires the Secretary of Transportation with the advice of the MRB to “establish, review, and revise medical standards for operators of Commercial Motor Vehicles (CMVs) that will ensure that the physical condition of operators is adequate to enable them operate the vehicles safely.” FMCSA is planning updates to the physical qualification regulations of CMV drivers, and the MRB will provide the necessary science-based guidance to establish realistic and responsible medical standards.
The MRB operates in accordance with FACA as announced in the Federal Register (70 FR 57642, October 3, 2005). The MRB is charged initially with the review of all current FMCSA medical standards (49 CFR 391.41), as well as making recommendations for new science-based standards and guidelines to ensure that drivers operating CMVs in interstate commerce, as defined in CFR 390.5, are physically capable of doing so.
Attendance is open to the interested public, including medical examiners, motor carriers, drivers, and representatives of medical and scientific associations. Written comments for this MRB meeting will also be accepted beginning on December 7, 2009 and continuing until January 20, 2010, and should include the docket ID that is listed in the ADDRESSES section.
During the MRB meeting, oral comments may be limited depending on how many persons wish to comment; and will be accepted on a first come, first serve basis as requestors register at the meeting. The comments must directly address relevant medical and scientific issues on the MRB meeting agenda. For more information, please view the following Web site: http://mrb.fmcsa.dot.gov.Start Signature
Issued on: December 2, 2009.
Larry W. Minor,
Associate Administrator for Policy and Program Development.
[FR Doc. E9-29112 Filed 12-4-09; 8:45 am]
BILLING CODE 4910-EX-P